Erlotinib effective against refractory bronchorrhea from advanced non-small cell lung cancer.
Thotathil
Ziad
Z
Long
Jeremy
J
D001706:Biopsy; D001999:Bronchoscopy; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications* / Q000175:diagnosis; D003937:Diagnosis, Differential; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005500:Follow-Up Studies; D006469:Hemoptysis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D013902:Radiography, Thoracic